Clinical Trials Directory

Trials / Completed

CompletedNCT00909896

Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy

Prospective, Double Arm, Comparative Study for the Evaluation of Postoperative Pain, QOL, and Determination of Inflammatory Markers In Patients Undergoing Robotics Versus Open Laparotomy Approach for Staging of Endometrial Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
142 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study is being done to evaluate the efficacy of robotic approach for staging of endometrial cancer as compared to an equivalent abdominal approach. The primary objective is to measure and compare postoperative pain at rest at several time points between two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer.

Detailed description

The primary objective is to measure and compare postoperative pain at rest at several time points (24 +/-4hours, 48 +/-4hours, and 72 +/-4hours) between the two groups of patients undergoing either robotic or open laparotomy approach for staging of endometrial cancer. Post operative Quality of Life will also be collected at several time points. The total amount of post operative opioid requirements during the first 24hours between patients undergoing either robotic or open laparotomy approach surgery. The survival status every four months for the first two years will be monitored, then every 6 months for up to 5 years. The primary endpoint is the mean difference in post operative pain VAS scores reported by subjects at rest at the following time points: 24+/-4, 48+/-4, and 72+/-4 hours between both groups after surgery has been completed.

Conditions

Timeline

Start date
2009-04-08
Primary completion
2013-01-29
Completion
2013-01-29
First posted
2009-05-29
Last updated
2018-04-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00909896. Inclusion in this directory is not an endorsement.